About the Authors

Gerardo Chowell
Mathematical, Computational & Modeling Sciences Center, School of Human Evolution and Social Change, Arizona State University, Tempe, Arizona, United States of America

Gerardo Chowell, Cécile Viboud, Lone Simonsen, James Tamerius, Mark A. Miller
Division of Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America

Santiago Echevarría-Zuno
Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Mexico City

Lone Simonsen
Department of Global Health, School of Public Health and Health Services, George Washington University, Washington (D.C.), United States of America

James Tamerius
School of Geography and Development, University of Arizona, Tucson, Arizona, United States of America

Víctor H. Borja-Aburto
Coordinación de Vigilancia Epidemiológica y Apoyo en Contingencias Instituto Mexicano del Seguro Social, Mier y Pesado 120, México, México

Corresponding Author


Competing Interests

LS received consulting fees from SDI, a health data warehouse business in Pennsylvania, and received research support from Pfizer for a pneumococcal vaccine study, but this is not relevant to the topic of this paper. MAM has been named on a US government patent for an experimental influenza vaccine as required by Federal requirements.

Author Contributions

ICMJE criteria for authorship read and met: GC SEZ CV LS JT MAM VHBA. Agree with the manuscript's results and conclusions: GC SEZ CV LS JT MAM VHBA. Designed the experiments/the study: GC SEZ CV LS VHBA. Analyzed the data: GC CV VHBA. Collected data/did experiments for the study: GC SEZ VHBA. Enrolled patients: SEZ VHBA. Wrote the first draft of the paper: GC. Contributed to the writing of the paper: GC SEZ CV LS MAM VHBA. Developed the absolute humidity database: JT.